Boehringer Ingelheim Venture Fund
boehringer-ingelheim-venture.com Corporate venture arm
About
Evergreen fund of Boehringer Ingelheim, established in 2010; a seed and Series A investor in first-in-class therapeutics, mainly pre-clinical.
- Kind
- Corporate venture arm
- Website
- boehringer-ingelheim-venture.com
- Parent company
- Boehringer Ingelheim
- Stages
- Seed and Series A
- Fund size
- €350 million evergreen fund
- Presence
- EU, US and China
Venture arms of operating companies, such as technology, pharmaceutical, automotive, energy and financial companies, that invest in outside startups, often ones whose products fit the parent's business. All corporate venture arms.
Source
About this data
Compiled by hand on 2026-10-11 from each organization's own website; no directory or ranking was copied. source_url is the page on the organization's site that was fetched that day and that the summary rests on. The summary is our own sentence. Facts repeat what the site says: the parent company, the stages it invests at, and a check size only where the site gives one. City, state and country are given only where the site states a single home; where it lists several offices they are in the facts instead. figure_usd is a fund size, committed capital or assets-under-management figure the organization states in US dollars on its site, with figure_label saying which; figures stated in other currencies are left in the facts unconverted, and amounts invested to date are facts, not figures. Nothing is estimated. Left out: arms whose pages could not be fetched, answered with a block page, or showed no sign of an update since 2024. As of October 11, 2026. Source: Websites of the corporate venture arms listed. Organizations only: no individuals are listed. A listing is a public record, not a recommendation.